|
| Register for our Free Newsletters |
|
 |
|
|
|
|
|
|
|
|
| Other Carouselweb publications |
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
Pioneer Surgical Technology introduces new bone graft substitute to US market
|
|
Pioneer Surgical Technology
: 15 October, 2008 (New Product) |
|
|
Pioneer Surgical Technology has released its FortrOss bone graft substitute to the US market. |
|
The novel biologic will make its public debut at the 23rd Annual Meeting of the North American Spine Society (NASS) in Toronto, Canada. The FortrOss bone void filler, utilizing the power of nanotechnology for orthopaedic applications, is a scaffold for the in-growth of new bone when superior bone regeneration is required.
Pioneer's chief executive officer and chairman of the board, Matthew N Songer, MD, MBA said, 'The Pioneer Orthobiologics team has reached a huge milestone with the release of the FortrOss. This is the culmination of over 10 years work by each of the two companies, Encelle and Angstrom Medica that were acquired by Pioneer in 2007.'
The FortrOss bone void filler combines the nanotechnology of nanOss hydroxyapatite with the bone growth promotion of E-Matrix scaffold. The FortrOss bone void filler is the most advanced on the market. The FortrOss osteoconductive matrix utilises Pioneer's nanOss technology and is designed to mimic the nanostructures inherent in bone tissue.
According to Dr Edward Ahn, vice president of biomaterials at Pioneer stated, 'Because the nanOss hydroxyapatite in FortrOss resembles the size, shape, and chemistry of native bone, bone tissue has a great affinity for nanOss and recognizes it as native tissue. This mimicry of native bone makes nanOss superior to other calcium phosphates on the market.'
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
